Oorsprong van het eerstegraads netwerk van Margaret Galluzzi
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
17
| Public Company | Medical Specialties | 17 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Margaret Galluzzi via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Corporate Officer/Principal | |
Sanofi Pasteur MSD SA (Spain)
Sanofi Pasteur MSD SA (Spain) Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Sanofi Pasteur MSD SA is a company based in Madrid, Spain. The Spanish company develops vaccines. | Pharmaceuticals: Major | Director/Board Member | |
Smag Consulting SARL | Chief Executive Officer | ||
MSD Vaccines Ltd.
MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology MSD Vaccines Ltd. manufactures and supplies vaccines. Its main way of achieving this goal is to develop and make available innovative vaccines against a wide spectrum of diseases. It also dedicated to increasing the understanding of the value of vaccines and vaccination by providing relevant and accurate information on their quality, safety and efficacy. The company was founded in 1975 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
Sanofi España SA | Director/Board Member | ||
Sanofi Pasteur MSD SA | Corporate Officer/Principal | ||
SARTORIUS STEDIM BIOTECH | Medical Specialties | Director/Board Member | |
ESSEC Business School | College/University | Masters Business Admin | |
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
VALNEVA | Biotechnology | Chairman | |
Fordham University
Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Masters Business Admin | |
APOGEE THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Investor Relations Contact | |
BIOMX INC. | Biotechnology | Investor Relations Contact | |
George Washington University | College/University | Undergraduate Degree | |
AIG Global Investment Group, Inc.
AIG Global Investment Group, Inc. Investment ManagersFinance Part of American International Group, Inc., AIG Global Investment Group, Inc. provides investment advisory services. The company is based in New York, NY. The CEO of the company is Win Jay Neuger. | Investment Managers | Corporate Officer/Principal | |
J.C. Flowers & Co. LLC
J.C. Flowers & Co. LLC Investment ManagersFinance J.C. Flowers & Co. LLC (J.C. Flowers & Co.) is a private equity firm founded in 1998 by J. Christopher Flowers. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
Institut Supérieur de Gestion | College/University | Graduate Degree | |
Université Paris II Panthéon Assas | College/University | Graduate Degree | |
Capgemini Consulting SAS
Capgemini Consulting SAS Miscellaneous Commercial ServicesCommercial Services Capgemini Consulting SAS provides management consulting and outsourcing services. The firm advises and supports organizations in transforming their business. The company was founded on July 12, 2004 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Mitrychem SAS | Corporate Officer/Principal | ||
Impulse Consulting Ltd. | Director/Board Member | ||
Onward Therapeutics SA
Onward Therapeutics SA BiotechnologyHealth Technology Onward Therapeutics SA is a Swiss development stage oncology company that focuses on identifying innovative technologies and developing breakthrough medicines for cancer treatment. The private company was founded by Alain Herrera and is based in Biopole, Switzerland, a life sciences campus in Epalinges, near Lausanne. The company acquires licenses for potential development candidates and invests in partners with transformative technology platforms. Onward recently licensed a preclinical stage bispecific antibody targeting two immune checkpoints and invested in the series A financing round in Biomunex Pharmaceuticals SAS. Onward also has an affiliate in Montpellier, France, and an office in Boston. | Biotechnology | Founder | |
EMERCell SAS
EMERCell SAS Pharmaceuticals: MajorHealth Technology EMERCell SAS is an oncology company based in Montpellier, France. The French company is focused on developing a platform technology to produce off-the-shelf allogenic natural killer (NK) cells. The company's lead drug candidate, NK-001, is intended for the treatment of lymphoma patients who are refractory to conventional therapies. EMERCell collaborates with numerous industrial and academic partners and has received support from the Occitanie region (ADI) and Bpifrance. The company was founded in 2013 by Patrick Henno and Martin Villalba and is a member of Eurobiomed. | Pharmaceuticals: Major | Director/Board Member | |
Gustave Roussy Transfert
Gustave Roussy Transfert Miscellaneous Commercial ServicesCommercial Services Gustave Roussy Transfert is a subsidiary of Gustave Roussy, the first cancer control center in France, which places innovation at the heart of care and research against cancer. The private company is based in Villejuif, France. The French company's main mission is to identify, protect, promote, and support the scientific, technological, and medical resources of Gustave Roussy. Gustave Roussy Transfert has designed a program called "Better Living Cancer" to support cancer patients during and after treatments through complementary approaches and practices to improve their quality of life. The program includes physical activity sessions, mindfulness meditation courses, and aesthetic care. | Miscellaneous Commercial Services | Director/Board Member | |
Pharmaengine Europe SARL
Pharmaengine Europe SARL Pharmaceuticals: MajorHealth Technology Part of PharmaEngine, Inc., Pharmaengine Europe SARL develops pharmaceutical products for cancer diseases. The company is based in Paris, France. The CEO of the French company is Alain Herrera. | Pharmaceuticals: Major | Chief Executive Officer | |
Sanofi Pasteur MSD Ltd. (Ireland)
Sanofi Pasteur MSD Ltd. (Ireland) BiotechnologyHealth Technology Part of Merck & Co., Inc., Sanofi Pasteur MSD Ltd. is a company based in Dublin, Ireland. The Irish company develops and produces vaccines. | Biotechnology | Director/Board Member | |
Roc SA
Roc SA Real Estate DevelopmentFinance Roc SA provides housing development services. | Real Estate Development | Corporate Officer/Principal | |
ISOFOL MEDICAL AB | Pharmaceuticals: Major | Director/Board Member | |
Fight Cancer Global, Llc
Fight Cancer Global, Llc Information Technology ServicesTechnology Services Fight Cancer Global, LLC provides a network platform aimed at solving the isolation problems faced by cancer patients. The private company is based in Houston, TX. | Information Technology Services | Director/Board Member | |
Servier Pharmaceuticals LLC
Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company is based in Boston, MA. Servier Pharmaceuticals continues to build a treatment portfolio with a current focus on oncology within acute lymphoblastic leukemia. The company invests in innovative research and development through development or partnerships to best address the unmet needs of patients. Additionally, the company is proud to offer financial assistance to not only support patients and their families but a variety of focused advocacy groups and healthcare professionals as well. Servier Pharmaceuticals is committed to engaging with patients, caregivers, families, and patient organizations to ensure their voices are heard in every initiative. The company's responsibility is to help make the world a better place for patients and their families, and it strives to have consistent and concise transparency throughout all clinical trials and research and development for the benefit of all patients. The company was founded in 1954. The CEO is David K. Lee. | Pharmaceuticals: Major | Director of Finance/CFO | |
University of Leiden | College/University | Graduate Degree | |
Olin Business School | College/University | Masters Business Admin | |
University of Maryland | College/University | Undergraduate Degree | |
Institut Supérieur d'Electronique de Paris | College/University | Director/Board Member | |
Ecole Nationale des Ponts et Chaussées | College/University | Corporate Officer/Principal | |
Institut Mines-Télécom
Institut Mines-Télécom Miscellaneous Commercial ServicesCommercial Services Institut Mines-Télécom provides information technology education services. It is an organization for higher education and research in the information and communication technologies and sciences. The firm also provides information technology education services. The company was founded in 1844 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
Sciences Po | College/University | Undergraduate Degree | |
École Normale Supérieure | College/University | Doctorate Degree | |
Axa Research Fund | Founder | ||
AXA Partners Holdings Ltd.
AXA Partners Holdings Ltd. Multi-Line InsuranceFinance AXA Partners Holdings Ltd. provides accident, sickness, and unemployment insurance services. The company was founded on September 29, 2003 and is headquartered in London, the United Kingdom. | Multi-Line Insurance | Human Resources Officer | |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ONCTERNAL THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
M2care SAS
M2care SAS Miscellaneous Commercial ServicesCommercial Services M2care SAS is a French healthcare company founded in 2017. The company is based in Lyon, France. M2care is a team of passionate entrepreneurs who invest in human and financial value to co-found, co-operate, and co-develop innovative projects in the healthcare sector until they reach the patient. | Miscellaneous Commercial Services | Director/Board Member | |
New York University School of Medicine | College/University | Doctorate Degree | |
Hunter College | College/University | Undergraduate Degree |
Statistieken
Internationaal
Frankrijk | 21 |
Verenigde Staten | 17 |
Verenigd Koninkrijk | 4 |
Spanje | 3 |
Portugal | 2 |
Sectoraal
Health Technology | 19 |
Consumer Services | 15 |
Finance | 7 |
Commercial Services | 5 |
Technology Services | 2 |
Operationeel
Corporate Officer/Principal | 44 |
Director/Board Member | 38 |
Chief Executive Officer | 12 |
Independent Dir/Board Member | 11 |
Chairman | 9 |
Sterkste connecties
Insiders | |
---|---|
Anne-Marie Graffin | 22 |
Gary Phillips | 20 |
Alain Herrera | 17 |
Enno Spillner | 13 |
Laurent Condomine | 11 |
Laurent Lévy | 9 |
Noël Kurdi | 9 |
Anne-Juliette Hermant | 9 |
Louis Kayitalire | 8 |
Edwina Baskin-Bey | 7 |
Philippe Mauberna | 6 |
Bart van Rhijn | 5 |
Patrick Tricoli | 2 |
Brandon Owens | 2 |
Ventzislav Vassilev | 1 |
- Beurs
- Insiders
- Margaret Galluzzi
- Bedrijfsconnecties